FDA OKs New Therapy for Some Hemophilia Patients - NBC4 Washington
National & International News
The day’s top national and international news

FDA OKs New Therapy for Some Hemophilia Patients

Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that

    Winter Olympics PyeongChang 2018 Medal Count
    Country
    Total
    1
    Norway
    13141138
    2
    Canada
    1181029
    3
    Germany
    138728
    processing...

    NEWSLETTERS

    Mother of Five Scared Straight After Heart Attack in her 40s
    AP/Genentech, Inc.
    This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.

    Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that.

    Genentech, a subsidiary of Swiss drugmaker Roche, says that's half the cost of the only other option for patients with this resistance. That treatment requires an IV drip several times a week.

    Pigeon Beauty Contest Held in Iraq

    [NATL] Pigeon Beauty Contest Held in Iraq

    More than 300 trumpeter pigeons competed in an Iraqi beauty contest. It’s the first of its kind in the country, according to pageant organizers.

    (Published Thursday, Feb. 22, 2018)

    Hemophilia mostly affects males.